Table of Contents
1: EXECUTIVE SUMMARY
A MIX OF TRADITIONAL AND EMERGING TESTING TECHNOLOGIES
DRIVERS
THE WORLD INFECTIOUS DISEASE TESTING MARKET
Table 1-1: Infectious Disease Diagnostic Test Market, 2017-2025 ($ millions)
Major Findings of the Report
Growth Rates by Type of Testing Product
Figure 1-1: Growth Rate Percentage by Type of Testing Product
COMPANIES IN THE MARKET
SCOPE AND METHODOLOGY
2: INTRODUCTION
MOLECULAR TESTING FOR INFECTIOUS DISEASES
Immunoassay vs. Molecular
TYPES OF INFECTIOUS DISEASE TESTING
HEPATITIS TESTING
Figure 2-1 New Cases Hepatitis, U.S.
Figure 2-2: Hepatitis Market Breakout by Product Type Immunoassay,
Molecular, Point of Care
HIV TESTING
Nucleic Acid Tests
Figure 2-3: HIV Testing by Type of Test (POC, Immunoassay, Molecular)
Table 2-1: Selected EIA HIV Assays
Table 2-2: Selected Western Blot HIV Assays
Table 2-3: Selected Indirect Fluorescent Antibody HIV Assays
Line Immunoassay
Combination Tests
Table 2-4: Selected Combination HIV Assays
Table 2-5: Selected Nucleic Acid HIV Assays
Table 2-6: Selected HIV Assays Used for Screening
Sexually Transmitted Diseases
TORCH
Influenza Rapid and POC Testing
BLOOD TESTING
Immunoassays
Automated Blood Typing and Screening Methods
Molecular Methods
Reducing Blood Typing Errors
POC INFECTIOUS DISEASE TESTING
MICROBIOLOGY
Chromogenic Media
Blood Culture
Rapid Micro Tests
SEPSIS
HOSPITAL-ACQUIRED INFECTIONS (HAIS)
Table 2-7: Frequency of the Most Common Nosocomial Infections
Figure 2-4: HAI Costs per Patient Stay
Product Examples
Products – Becton, Dickinson
Products – Cepheid
Products – Meridian Biosciences
Products – Luminex Corporation
Products – Quest Diagnostics
Products – Quidel / Life Technologies
Products – DiaSorin
Hospital-Acquired Pneumonia
Table 2-8: Significant Approvals for Detecting Serious Healthcare Infections
TORCH
TRENDS TO WATCH
Vaccines and Their Impact on Infectious Disease Markets
Globalization through Trade and Travel
More Walk-In Clinic Testing
Skipping the Pathogen: Syndromic Testing
IVD Companies Mix and Match
Table 2-9: Selected Menu Expansion by Partnering and Acquisitions
Phage-based Assays
Emerging Microbiome Diagnostic Companies
New Infectious Disease Threats
Sequencing for HIV
Greater Outside-the-U.S. Focus
3: WORLD INFECTIOUS DISEASE MARKET ANALYSIS
Table 3-1: Global Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-2: Global Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-3: Global Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-4: Global HIV, Labs and POC Market, 2017-2025
Table 3-5: Global Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-6: Global STDs and HPV Market, 2017-2025
Table 3-7: Global TORCH Market, 2017-2025
Table 3-8: Global TB, Labs and POC, 2017-2025
Table 3-9: Global ID/AST Market (Auto, Manual) 2017-2025
Table 3-10: Global Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-11: Global Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-12: Global Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
GLOBAL MARKETS FOR INFECTIOUS DISEASE MARKETS BY COUNTRY
United States
Table 3-13: U.S. Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-14: U.S. Respiratory Disease Market (Flu, Strep A, RSV) 2017-2025
Table 3-15: U.S. Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-16: U.S. HIV, Labs and POC Market, 2017-2025
Table 3-17: U.S. Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-18: U.S. STDs and HPV Market, 2017-2025
Table 3-19: U.S. TORCH Market, 2017-2025
Table 3-20: Tuberculosis Testing Market, 2017-2025
Table 3-21: U.S. ID/AST Market (Auto, Manual) 2017-2025
Table 3-22: U.S. Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-23: U.S. Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-24: U.S. Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Canada
Table 3-25: Canada Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-26: Canada Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-27: Canada Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-28: Canada HIV, Labs and POC Market, 2017-2025
Table 3-29: Canada Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-30: Canada STDs and HPV Market, 2017-2025
Table 3-31: Canada TORCH Market, 2017-2025
Table 3-32: Canada TB, Labs and POC, 2017-2025
Table 3-33: Canada ID/AST Market (Auto, Manual) 2017-2025
Table 3-34: Canada Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-35: Canada Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-36: Canada Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Germany
Table 3-37: Germany Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-38: Germany Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-39: Germany Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-40: Germany HIV, Labs and POC Market, 2017-2025
Table 3-41: Germany Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-42: Germany STDs and HPV Market, 2017-2025
Table 3-43: Germany TORCH Market, 2017-2025
Table 3-44: Germany TB, Labs and POC, 2017-2025
Table 3-45: Germany ID/AST Market (Auto, Manual) 2017-2025
Table 3-46: Germany Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-47: Germany Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-48: Germany Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Spain
Table 3-49: Spain Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-50: Spain Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-51: Spain Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-52: Spain HIV, Labs and POC Market, 2017-2025
Table 3-53: Spain Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-54: Spain STDs and HPV Market, 2017-2025
Table 3-55: Spain TORCH Market, 2017-2025
Table 3-56: Spain TB, Labs and POC, 2017-2025
Table 3-57: Spain ID/AST Market (Auto, Manual) 2017-2025
Table 3-58: Spain Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-59: Spain Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-60: Spain Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
France
Table 3-61: France Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-62: France Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-63: France Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-64: France HIV, Labs and POC Market, 2017-2025
Table 3-65: France Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-66: France STDs and HPV Market, 2017-2025
Table 3-67: France TORCH Market, 2017-2025
Table 3-68: France TB, Labs and POC, 2017-2025
Table 3-69: France ID/AST Market (Auto, Manual) 2017-2025
Table 3-70: France Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-71: France Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-72: France Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Italy
Table 3-73: Italy Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-74: Italy Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-75: Italy Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-76: Italy HIV, Labs and POC Market, 2017-2025
Table 3-77: Italy Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-78: Italy STDs and HPV Market, 2017-2025
Table 3-79: Italy TORCH Market, 2017-2025
Table 3-80: Italy TB, Labs and POC, 2017-2025
Table 3-81: Italy ID/AST Market (Auto, Manual) 2017-2025
Table 3-82: Italy Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-83: Italy Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-84: Italy Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
U.K.
Table 3-85: U.K. Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-86: U.K. Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-87: U.K. Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-88: U.K. HIV, Labs and POC Market, 2017-2025
Table 3-89: U.K. Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-90: U.K. STDs and HPV Market, 2017-2025
Table 3-91: U.K. TORCH Market, 2017-2025
Table 3-92: U.K. TB, Labs and POC, 2017-2025
Table 3-93: U.K. ID/AST Market (Auto, Manual) 2017-2025
Table 3-94: U.K. Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-95: U.K. Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-96: U.K. Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Other EU
Table 3-97: Other EU Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-98: Other EU Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-99: Other EU Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-100: Other EU HIV, Labs and POC Market, 2017-2025
Table 3-101: Other EU Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-102: Other EU STDs and HPV Market, 2017-2025
Table 3-103: Other EU TORCH Market, 2017-2025
Table 3-104: Other EU TB, Labs and POC, 2017-2025
Table 3-105: Other EU ID/AST Market (Auto, Manual) 2017-2025
Table 3-106: Other EU Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-107: Other EU Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-108: Other EU Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Eastern Europe
Table 3-109: Eastern Europe Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-110: Eastern Europe Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025 . 115
Table 3-111: Eastern Europe Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-112: Eastern Europe HIV, Labs and POC Market, 2017-2025
Table 3-113: Eastern Europe Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-114: Eastern Europe STDs and HPV Market, 2017-2025
Table 3-115: Eastern Europe TORCH Market, 2017-2025
Table 3-116: Eastern Europe TB, Labs and POC, 2017-2025
Table 3-117: Eastern Europe ID/AST Market (Auto, Manual) 2017-2025
Table 3-118: Eastern Europe Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-119: Eastern Europe Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-
2025
Table 3-120: Eastern Europe Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests,
Home OTC, Other), 2017-2025
Japan
Table 3-121: Japan Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-122: Japan Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-123: Japan Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-124: Japan HIV, Labs and POC Market, 2017-2025
Table 3-125: Japan Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-126: Japan STDs and HPV Market, 2017-2025
Table 3-127: Japan TORCH Market, 2017-2025
Table 3-128: Japan TB, Labs and POC, 2017-2025
Table 3-129: Japan ID/AST Market (Auto, Manual) 2017-2025
Table 3-130: Japan Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-131: Japan Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-132: Japan Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Australia
Table 3-133: Australia Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-134: Australia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-135: Australia Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-136: Australia HIV, Labs and POC Market, 2017-2025
Table 3-137: Australia Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-138: Australia STDs and HPV Market, 2017-2025
Table 3-139: Australia TORCH Market, 2017-2025
Table 3-140: Australia TB, Labs and POC, 2017-2025
Table 3-141: Australia ID/AST Market (Auto, Manual) 2017-2025
Table 3-142: Australia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-143: Australia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-144: Australia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Singapore
Table 3-145: Singapore Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-146: Singapore Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-147: Singapore Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-148: Singapore HIV, Labs and POC Market, 2017-2025
Table 3-149: Singapore Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-150: Singapore STDs and HPV Market, 2017-2025
Table 3-151: Singapore TORCH Market, 2017-2025
Table 3-152: Singapore TB, Labs and POC, 2017-2025
Table 3-153: Singapore ID/AST Market (Auto, Manual) 2017-2025
Table 3-154: Singapore Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-155: Singapore Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-156: Singapore Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
China
Table 3-157: China Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-158: China Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-159: China Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-160: China HIV, Labs and POC Market, 2017-2025
Table 3-161: China Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-162: China STDs and HPV Market, 2017-2025
Table 3-163: China TORCH Market, 2017-2025
Table 3-164: China TB, Labs and POC, 2017-2025
Table 3-165: China ID/AST Market (Auto, Manual) 2017-2025
Table 3-166: China Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Infectious Disease Diagnostic Testing: World Market Analysis
February viii 2018 © Kalorama Information
Table 3-167: China Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-168: China Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Malaysia
Table 3-169: Malaysia Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-170: Malaysia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-171: Malaysia Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-172: Malaysia HIV, Labs and POC Market, 2017-2025
Table 3-173: Malaysia Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-174: Malaysia STDs and HPV Market, 2017-2025
Table 3-175: Malaysia TORCH Market, 2017-2025
Table 3-176: Malaysia TB, Labs and POC, 2017-2025
Table 3-177: Malaysia ID/AST Market (Auto, Manual) 2017-2025
Table 3-178: Malaysia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-179: Malaysia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-180: Malaysia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Turkey
Table 3-181: Turkey Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-182: Turkey Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-183: Turkey Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-184: Turkey HIV, Labs and POC Market, 2017-2025
Table 3-185: Turkey Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-186: Turkey STDs and HPV Market, 2017-2025
Table 3-187: Turkey TORCH Market, 2017-2025
Table 3-188: Turkey TB, Labs and POC, 2017-2025
Table 3-189: Turkey ID/AST Market (Auto, Manual) 2017-2025
Table 3-190: Turkey Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-191: Turkey Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-192: Turkey Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Saudi Arabia
Table 3-193: Saudi Arabia Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-194: Saudi Arabia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-195: Saudi Arabia Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-196: Saudi Arabia HIV, Labs and POC Market, 2017-2025
Table 3-197: Saudi Arabia Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-198: Saudi Arabia STDs and HPV Market, 2017-2025
Table 3-199: Saudi Arabia TORCH Market, 2017-2025
Table 3-200: Saudi Arabia TB, Labs and POC, 2017-2025
Table 3-201: Saudi Arabia ID/AST Market (Auto, Manual) 2017-2025
Table 3-202: Saudi Arabia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-203: Saudi Arabia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-
2025
Table 3-204: Saudi Arabia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
South Africa
Table 3-205: South Africa Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-206: South Africa Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-207: South Africa Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-208: South Africa HIV, Labs and POC Market, 2017-2025
Table 3-209: South Africa Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-210: South Africa STDs and HPV Market, 2017-2025
Table 3-211: South Africa TORCH Market, 2017-2025
Table 3-212: South Africa TB, Labs and POC, 2017-2025
Table 3-213: South Africa ID/AST Market (Auto, Manual) 2017-2025
Table 3-214: South Africa Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-215: South Africa Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-
2025
Table 3-216: South Africa Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Russia
Table 3-217: Russia Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-218: Russia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-219: Russia Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-220: Russia HIV, Labs and POC Market, 2017-2025
Table 3-221: Russia Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-222: Russia STDs and HPV Market, 2017-2025
Table 3-223: Russia TORCH Market, 2017-2025
Table 3-224: Russia TB, Labs and POC, 2017-2025
Table 3-225: Russia ID/AST Market (Auto, Manual) 2017-2025
Table 3-226: Russia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-227: Russia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-228: Russia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
India
Table 3-229: India Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-230: India Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-231: India Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-232: India HIV, Labs and POC Market, 2017-2025
Table 3-233: India Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-234: India STDs and HPV Market, 2017-2025
Table 3-235: India TORCH Market, 2017-2025
Table 3-236: India TB, Labs and POC, 2017-2025
Table 3-237: India ID/AST Market (Auto, Manual) 2017-2025
Table 3-238: India Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-239: India Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-240: India Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Indonesia
Table 3-241: Indonesia Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-242: Indonesia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-243: Indonesia Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-244: Indonesia HIV, Labs and POC Market, 2017-2025
Table 3-245: Indonesia Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-246: Indonesia STDs and HPV Market, 2017-2025
Table 3-247: Indonesia TORCH Market, 2017-2025
Table 3-248: Indonesia TB, Labs and POC, 2017-2025
Table 3-249: Indonesia ID/AST Market (Auto, Manual) 2017-2025
Table 3-250: Indonesia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-251: Indonesia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-252: Indonesia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Brazil
Table 3-253: Brazil Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-254: Brazil Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-255: Brazil Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-256: Brazil HIV, Labs and POC Market, 2017-2025
Table 3-257: Brazil Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-258: Brazil STDs and HPV Market, 2017-2025
Table 3-259: Brazil TORCH Market, 2017-2025
Table 3-260: Brazil TB, Labs and POC, 2017-2025
Table 3-261: Brazil ID/AST Market (Auto, Manual) 2017-2025
Table 3-262: Brazil Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-263: Brazil Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-264: Brazil Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Taiwan
Table 3-265: Taiwan Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-266: Taiwan Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-267: Taiwan Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-268: Taiwan HIV, Labs and POC Market, 2017-2025
Table 3-269: Taiwan Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-270: Taiwan STDs and HPV Market, 2017-2025
Table 3-271: Taiwan TORCH Market, 2017-2025
Table 3-272: Taiwan TB, Labs and POC, 2017-2025
Table 3-273: Taiwan ID/AST Market (Auto, Manual) 2017-2025
Table 3-274: Taiwan Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-275: Taiwan Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-276: Taiwan Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
South Korea
Table 3-277: South Korea Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-278: South Korea Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-279: South Korea Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-280: South Korea HIV, Labs and POC Market, 2017-2025
Table 3-281: South Korea Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-282: South Korea STDs and HPV Market, 2017-2025
Table 3-283: South Korea TORCH Market, 2017-2025
Table 3-284: South Korea TB, Labs and POC, 2017-2025
Table 3-285: South Korea ID/AST Market (Auto, Manual), 2017-2025
Table 3-286: South Korea Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-287: South Korea Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-
2025
Table 3-288: South Korea Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Mexico
Table 3-289: Mexico Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-290: Mexico Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-291: Mexico Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-292: Mexico HIV, Labs and POC Market, 2017-2025
Table 3-293: Mexico Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-294: Mexico STDs and HPV Market, 2017-2025
Table 3-295: Mexico TORCH Market, 2017-2025
Table 3-296: Mexico TB, Labs and POC, 2017-2025
Table 3-297: Mexico ID/AST Market (Auto, Manual), 2017-2025
Table 3-298: Mexico Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Infectious Disease Diagnostic Testing: World Market Analysis
February xii 2018 © Kalorama Information
Table 3-299: Mexico Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-300: Mexico Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Chile
Table 3-301: Chile Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-302: Chile Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-303: Chile Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-304: Chile HIV, Labs and POC Market, 2017-2025
Table 3-305: Chile Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-306: Chile STDs and HPV Market, 2017-2025
Table 3-307: Chile TORCH Market, 2017-2025
Table 3-308: Chile TB, Labs and POC, 2017-2025
Table 3-309: Chile ID/AST Market (Auto, Manual), 2017-2025
Table 3-310: Chile Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-311: Chile Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-312: Chile Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
Columbia
Table 3-313: Columbia Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-314: Columbia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-315: Columbia Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-316: Columbia HIV, Labs and POC Market, 2017-2025
Table 3-317: Columbia Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-318: Columbia STDs and HPV Market, 2017-2025
Table 3-319: Columbia TORCH Market, 2017-2025
Table 3-320: Columbia TB, Labs and POC, 2017-2025
Table 3-321: Columbia ID/AST Market (Auto, Manual) 2017-2025
Table 3-322: Columbia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-323: Columbia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-324: Columbia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Other LATAM
Table 3-325: Other LATAM Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-326: Other LATAM Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-327: Other LATAM Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-328: Other LATAM HIV, Labs and POC Market, 2017-2025
Table 3-329: Other LATAM Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-330: Other LATAM STDs and HPV Market, 2017-2025
Table 3-331: Other LATAM TORCH Market, 2017-2025
Table 3-332: Other LATAM TB, Labs and POC, 2017-2025
Table 3-333: Other LATAM ID/AST Market (Auto, Manual) 2017-2025
Table 3-334: Other LATAM Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-335: Other LATAM Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-
2025
Table 3-336: Other LATAM Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home
OTC, Other), 2017-2025
Rest of World
Table 3-337: ROW Blood Screening Market (Immunoassay, NAT), 2017-2025
Table 3-338: ROW Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
Table 3-339: ROW Malaria and Dengue Diagnostic Market, 2017-2025
Table 3-340: ROW HIV, Labs and POC Market, 2017-2025
Table 3-341: ROW Hepatitis Testing (Lab-Based, POC), 2017-2025
Table 3-342: ROW STDs and HPV Market, 2017-2025
Table 3-343: ROW TORCH Market, 2017-2025
Table 3-344: ROW TB, Labs and POC, 2017-2025
Table 3-345: ROW ID/AST Market (Auto, Manual) 2017-2025
Table 3-346: ROW Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
Table 3-347: ROW Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
Table 3-348: ROW Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC,
Other), 2017-2025
4: COMPANIES IN THE MARKET
ABBOTT DIAGNOSTICS
Table 4-1: Abbott Recent Revenue History, 2013-2017 ($ million)
Table 4-2: Abbott’s Revenue in Selected Test Segments, 2013-2017 ($ million) (Histology (Vysis), Chem/Immuno, Hematology, Molecular, Point of Care, Diabetes)
Alere Acquisition Update
Core Lab
Coagulation
Infectious Diseases – Molecular
HIV
Alere Reader
Zika
BECKMAN COULTER, INC. / DANAHER
Table 4-3: Beckman Coulter, Inc. / Danaher Recent Revenue History, 2011-2017 ($ million, estimated)
Table 4-4: Beckman Coulter’s Revenue in Selected Test Segments ($ million, estimated), 2011-2016 (Routine Chemistry, Immunoassays, Hematology, Microbiology)
Immunoassays
BECTON, DICKINSON AND COMPANY (BD)
Table 4-5 Becton, Dickinson and Company (BD) Recent Revenue History, 2013-2017 (diagnostic systems, $ million)
Table 4-6: BD’s Revenue in Selected IVD Test Segments ($ million, estimated), 2013 (Molecular, Microbiology ID/AST, Microbiology media, Rapid Tests, Blood Culture)
BD Max Molecular
ID/AST
POC Veritor
BIOMÉRIEUX INC.
Table 4-7: bioMérieux Recent Revenue History, 2013-2017 (Total IVDs, $ million)
Table 4-8: bioMérieux’s Revenue in Selected IVD Test Segments ($ million), 2013-2017 (Microbiology, Immunoassays, Molecular, FilmArray)
Traditional Microbiology
Blood Culture
Immunoassays
Mass Spectrometry
BioFire Diagnostics Business
BIO-RAD LABORATORIES, INC
Table 4-9: Bio-Rad Laboratories Recent Revenue History, 2013-2017 (all diagnostics, $ million, estimated)
Table 4-10: Bio-Rad’s Revenue in Selected Product Segments ($ million, estimated), 2012-2016 (Quality Control, Immunoassays,
Microbiology (all), Blood Bank)
Quality Control
Blood Bank
Infectious Diseases – Molecular
Immunoassays
Droplet Digital PCR
Sequencing
CEPHEID / DANAHER
Table 4-11: Cepheid Recent Revenue History, 2013-2017 (clinical product sales, $ million)
Tuberculosis
Microbiology
Influenza
POC HIV
DANAHER CORPORATION
Table 4-12: Danaher Corp. Recent Revenue History, 2014-2017 ($ million – diagnostics – most recent years for which data is available,
estimated)
Table 4-13: Danaher’s Revenue in Selected Business Segments, 2013-2017 ($ million, estimated)
For 2016 vs 2015, Danaher Reported . . .
Beckman Coulter
Radiometer
Leica Biosystems
Cepheid
Radiometer A/S Profile
Table 4-14: Radiometer Recent Revenue History, 2012-2016 (estimated, core products, $ million)
Radiometer, POC
Radiometer, Critical Care
Radiometer, Immunoassays
GRIFOLS
Recent Revenue History
Table 4-15: Grifols Diagnostic Product Revenues, 2012-2017 ($ million, estimated) (Core, Blood Screen, Total)
2016 Summary as Reported by Grifols
Blood Transfusion Business
Blood Bank CLIA Lab
Coagulation
Acquisitions and Collaborations
HOLOGIC, INC.
Table 4-16: Hologic Recent Revenue History, 2013-2017 (total Dx; $ million)
Table 4-17: Hologic’s Revenue in Selected Segments ($ million), 2013-2017 (HPV (legacy), ThinPrep/cytology, Molecular, Blood Bank)
Panther Molecular System
Panther Fusion
Blood Bank – Zika Virus
INSILIXA, INC
Table 4-18: InSilixa Corporate Summary
Company Overview
Products
MERIDIAN BIOSCIENCE, INC
Table 4-19: Meridian BioScience Corporate Summary
Company Overview
Products
Performance Review
Table 4-20: Meridian Bioscience (2014-2017) ($ millions)
ORTHO CLINICAL DIAGNOSTICS
Table 4-21: Ortho Clinical Diagnostics Corporate Summary
Company Overview
Products
Company Financials
Table 4-22: Ortho Clinical Diagnostics Revenue (2014-2017) ($ millions)
PERKINELMER, INC. (PE)
Table 4-23: PerkinElmer Recent Revenue History, 2014-2017 ($ million, estimated)
Sequencing
Lab Services
Expansion
QIAGEN N.V.
Table 4-25: QIAGEN Recent Revenue History, 2013-2017 ($ million)
Table 4-26: QIAGEN Molecular IVD Product Revenues ($ million), 2013-2017 (HPV, TB, Other Molecular, Total IVD)
Tuberculosis
QUIDEL CORPORATION
Table 4-27: Quidel Recent Revenue History, 2013-2016 ($ million)
Immunoassays
The Solana Business
ROCHE DIAGNOSTICS
Table 4-28: Roche Diagnostics Recent Revenue History, 2011-2017 ($ millions)
Table 4-29: Roche’s Revenue in Selected Test Segments, 2013-2016 ($ millions, estimated) (Chemistry/Immuno, Diabetes, Molecular,
Histology)
Immunoassays
Global Access Program for HIV
cobas Liat System – POC
HPV
Blood Bank
SIEMENS HEALTHINEERS
Table 4-30: Siemens Recent Revenue History, 2012-2015 (total IVD; $ million)
Table 4-31: Siemens’ IVD Product Sales in Selected Test Segments, 2012-2015 ($ million) (Chemistry/Immunoassays, Coagulation,
Hematology, Molecular, Urinalysis, Blood Gases)
Immunoassays
THERMO FISHER SCIENTIFIC INC.
Table 4-32: Thermo Fisher Recent Revenue History, 2013-2016 (clinical diagnostics, $ million)
Table 4-33: Thermo Fisher Product Sales in Selected Test Segments, 2015-2016 ($ million) (Clinical products, Immunoassays,
Microbiology, Histology)
Microbiology
Molecular Test Business
Mass Spectrometry
TRINITY BIOTECH PLC
Table 4-34: Trinity Biotech Corporate Summary
Company Overview
Products
Company Financials
Table 4-35: Trinity Biotech Revenue (2014-2017) ($ thousands)
WAMA DIAGNOSTICA
Table 4-36: WAMA Diagnostica Corporate Summary
Company Overview
Products
WAVE 80 BIOSCIENCES
Table 4-37: Wave 80 Biosciences Corporate Summary
Company Overview
Products
XAGENIC
Table 4-38: Xagenic Corporate Summary
Company Overview
Products
